The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

Phase 4RecruitingNCT00768820

The Chaim Sheba Medical Center400 enrolled

Overview

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

400

Conditions

Velocardiofacial Syndrome Williams Syndrome Fragile X Syndrome

Interventions

methylphenidate, fluoxetin, risperidoneDRUG

first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * chromosomal deletion proven by FISH examination Exclusion Criteria:

Locations (1)

Schneider Children's Mediac Center of Israel

Petah Tikva, Israel

RECRUITING

Outcomes

Primary Outcomes

Measure that are used: psychological measures, molecular tests, responsiveness to medical treatments

Time frame: 2 years

Central Contacts

Doron Gothelf, MD

CONTACT

972-03-5302663 gothelf@post.tau.ac.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.